Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 13-Feb-2018

Barolock

Abstract

There are currently two trends that are leading to a major problem in longevity of current hip replacements. First, evidence shows that those requiring hip replacements are needing them at a younger and younger age. Second, advancing health care has extended the human life expectancy. Currently this population of people are going to need multiple hip replacements during their lifetime. Other issues including dislocation and particle wear also lead to need for painful revision surgery.

Barolock is an innovative biomedical device company focused on research and development of a new hip implant device. The Barolock hip incorporates a flexible membrane shell infused with a lubricant around the ball and socket that would allow for several improvements to the current standard hip implant on the market today. Our invention can be used as an addition to current gold standard hip products. There are three main improvements that the Barolock hip provides to the current standard hip replacement that will be discussed below.

Video

Original YouTube URL: Open

Introduction Video

Additional Questions

Who is your customer?

Orthopedic Surgeons

What problem does this idea/product solve or what market need does it serve?

Hip implant dislocation and re-implantation.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

It is a longer lasting safer design, due to the encapsulation of the joint.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

We have a PhD, MD, and other highly qualified individuals driven to make this product successful. Additionally we already have been awarded significant funds to create our business and move the idea forwards. We plan to move this company through pre-clinical testing and then market it to other larger corporations interested in the product.